Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/4601

TR 396 Rat Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                       MONOCHLOROACETIC ACID


NTP Experiment-Test: 05705-02                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/18/94
Route: GAVAGE                                                                                                     Time: 21:14:39




       Facility:  International Research and Development Corp.

       Chemical CAS #:  79-11-8

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15 MG/KG     30 MG/KG                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          70           70           70                                                  
  Scheduled Sacrifice                                 17           17           17                                                  
  Early Deaths                                                                                                                      
    Moribund                                          14           21           13                                                  
    Dead                                               2           11           13                                                  
    Dosing Accident                                                 2            1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                37           19           25                                                  
    Moribund                                                                     1                                                  
  Animals Examined Microscopically                    53           53           53                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (53)         (52)         (52)                                                
      Inflammation, Acute, Focal                                                 1 (2%)                                             
   Intestine Large, Cecum                             (53)         (53)         (51)                                                
      Autolysis                                                     3 (6%)                                                          
      Parasite Metazoan                                             1 (2%)                                                          
   Intestine Large, Colon                             (53)         (53)         (51)                                                
      Autolysis                                                     1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Parasite Metazoan                                8 (15%)      3 (6%)       6 (12%)                                            
   Intestine Large, Rectum                            (52)         (53)         (50)                                                
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Parasite Metazoan                                2 (4%)       1 (2%)       3 (6%)                                             
      Submucosa, Inflammation, Acute, Focal                                      1 (2%)                                             
   Intestine Small, Duodenum                          (53)         (51)         (51)                                                
      Autolysis                                                     1 (2%)                                                          
   Intestine Small, Ileum                             (53)         (53)         (48)                                                
      Autolysis                                                     3 (6%)                                                          
      Congestion                                                    2 (4%)                                                          
      Edema                                                         1 (2%)                                                          
      Hyperplasia, Lymphoid                            1 (2%)       2 (4%)                                                          
      Parasite Metazoan                                             1 (2%)                                                          
   Intestine Small, Jejunum                           (53)         (52)         (49)                                                
      Autolysis                                                     3 (6%)                                                          
   Liver                                              (53)         (53)         (53)                                                
      Angiectasis                                      1 (2%)                                                                       
      Angiectasis, Focal                               1 (2%)                    1 (2%)                                             
      Basophilic Focus                                16 (30%)      6 (11%)     16 (30%)                                            
      Basophilic Focus, Multiple                      21 (40%)     17 (32%)     14 (26%)                                            
      Congestion                                       1 (2%)       2 (4%)       1 (2%)                                             
      Cytoplasmic Alteration, Focal                    6 (11%)      3 (6%)       4 (8%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15 MG/KG     30 MG/KG                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Degeneration, Fatty                              1 (2%)       1 (2%)                                                          
      Hemorrhage, Focal                                1 (2%)                                                                       
      Hepatodiaphragmatic Nodule                       4 (8%)       1 (2%)       3 (6%)                                             
      Inflammation, Acute, Focal                       2 (4%)                    2 (4%)                                             
      Inflammation, Granulomatous, Multifocal         21 (40%)     19 (36%)     18 (34%)                                            
      Necrosis, Acute, Coagulative, Multifocal         1 (2%)                                                                       
      Necrosis, Acute, Focal                                        2 (4%)       1 (2%)                                             
      Vacuolization Cytoplasmic, Focal                 1 (2%)       1 (2%)                                                          
      Bile Duct, Hyperplasia                           7 (13%)      1 (2%)       3 (6%)                                             
      Hepatocyte, Hypertrophy, Focal                   1 (2%)                                                                       
   Mesentery                                          (4)                       (2)                                                 
      Inflammation, Chronic, Multifocal                1 (25%)                   1 (50%)                                            
      Fat, Necrosis, Focal                             3 (75%)                   2 (100%)                                           
   Pancreas                                           (53)         (53)         (51)                                                
      Atrophy, Focal                                  19 (36%)     15 (28%)     10 (20%)                                            
      Cytoplasmic Alteration, Focal                                 1 (2%)                                                          
      Inflammation, Chronic, Focal                     1 (2%)                                                                       
      Acinus, Hyperplasia                                                        1 (2%)                                             
   Salivary Glands                                    (53)         (53)         (53)                                                
      Atrophy, Focal                                                             1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia, Focal                                            1 (2%)                                                          
      Infiltration Cellular, Multifocal, Lymphocyte                              2 (4%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Duct, Inflammation, Chronic                      5 (9%)                    2 (4%)                                             
      Duct, Inflammation, Chronic Active               8 (15%)                   7 (13%)                                            
   Stomach, Forestomach                               (51)         (52)         (53)                                                
      Inflammation, Acute                              2 (4%)       3 (6%)       1 (2%)                                             
      Inflammation, Chronic                            1 (2%)                    1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)       1 (2%)                                                          
      Ulcer                                                                      1 (2%)                                             
      Epithelium, Hyperplasia                          6 (12%)      4 (8%)       4 (8%)                                             
      Muscularis, Hypertrophy, Focal                                             1 (2%)                                             
      Submucosa, Inflammation, Acute                                             1 (2%)                                             
   Stomach, Glandular                                 (53)         (53)         (53)                                                
      Infiltration Cellular, Focal, Lymphocyte                                   1 (2%)                                             
      Inflammation, Acute                                           1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Necrosis, Acute                                  1 (2%)       4 (8%)       3 (6%)                                             
      Pigmentation, Focal                                           1 (2%)                                                          
      Arteriole, Submucosa, Thrombosis                                           1 (2%)                                             
      Serosa, Inflammation, Chronic, Multifocal                                  1 (2%)                                             
      Submucosa, Inflammation, Chronic                                           1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15 MG/KG     30 MG/KG                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (53)         (53)         (53)                                                
      Inflammation, Chronic                           41 (77%)     31 (58%)     36 (68%)                                            
      Atrium Left, Thrombosis                          1 (2%)       2 (4%)                                                          
      Coronary Artery, Inflammation, Chronic                                     1 (2%)                                             
      Pericardium, Fibrosis, Focal                                               1 (2%)                                             
      Valve, Thrombosis                                                          1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (53)         (53)         (52)                                                
      Angiectasis, Focal                                                         1 (2%)                                             
      Congestion                                       1 (2%)       1 (2%)       2 (4%)                                             
      Ectasia                                          2 (4%)                                                                       
      Hemorrhage                                                    2 (4%)       1 (2%)                                             
      Hyperplasia, Focal                              10 (19%)      8 (15%)     12 (23%)                                            
      Hypertrophy                                      1 (2%)                                                                       
      Hypertrophy, Focal                               9 (17%)      4 (8%)       4 (8%)                                             
      Mineralization                                                1 (2%)                                                          
      Necrosis, Acute, Focal                                        1 (2%)                                                          
      Thrombosis                                                    1 (2%)                                                          
      Vacuolization Cytoplasmic, Diffuse                            2 (4%)                                                          
      Vacuolization Cytoplasmic, Focal                11 (21%)      9 (17%)      6 (12%)                                            
      Bilateral, Hyperplasia, Focal                                 1 (2%)                                                          
   Adrenal Gland, Medulla                             (52)         (52)         (53)                                                
      Hyperplasia, Focal                               4 (8%)                    4 (8%)                                             
   Islets, Pancreatic                                 (53)         (53)         (51)                                                
      Hyperplasia                                                   1 (2%)                                                          
   Parathyroid Gland                                  (43)         (43)         (42)                                                
      Congestion, Focal                                                          1 (2%)                                             
      Hyperplasia                                      1 (2%)                                                                       
   Pituitary Gland                                    (53)         (53)         (53)                                                
      Autolysis                                                                  1 (2%)                                             
      Congestion, Focal                                                          1 (2%)                                             
      Hemorrhage                                                                 2 (4%)                                             
      Pigmentation, Focal                              1 (2%)                                                                       
      Pars Distalis, Angiectasis                       6 (11%)      4 (8%)       5 (9%)                                             
      Pars Distalis, Cyst                             10 (19%)      4 (8%)       7 (13%)                                            
      Pars Distalis, Ectasia                                                     1 (2%)                                             
      Pars Distalis, Hyperplasia                       9 (17%)     12 (23%)     13 (25%)                                            
      Pars Distalis, Vacuolization Nuclear                                       1 (2%)                                             
   Thyroid Gland                                      (53)         (52)         (52)                                                
      Ultimobranchial Cyst                                          1 (2%)       1 (2%)                                             
      C-Cell, Hyperplasia                             20 (38%)      8 (15%)     16 (31%)                                            
      Follicle, Cyst                                                             1 (2%)                                             
      Follicular Cell, Hyperplasia                                               1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15 MG/KG     30 MG/KG                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (44)         (45)         (48)                                                
      Hyperplasia                                                   1 (2%)       1 (2%)                                             
      Hyperplasia, Squamous                                         1 (2%)                                                          
      Inflammation, Acute                              5 (11%)      8 (18%)      4 (8%)                                             
      Inflammation, Chronic                           11 (25%)      6 (13%)     12 (25%)                                            
      Inflammation, Chronic Active                     6 (14%)      1 (2%)       5 (10%)                                            
   Ovary                                              (53)         (53)         (53)                                                
      Atrophy                                                                    1 (2%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Follicle, Cyst                                   6 (11%)      2 (4%)       5 (9%)                                             
      Periovarian Tissue, Cyst                         1 (2%)                    1 (2%)                                             
   Uterus                                             (53)         (53)         (53)                                                
      Dilatation                                       2 (4%)       5 (9%)       3 (6%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Inflammation, Acute                              2 (4%)                                                                       
      Inflammation, Chronic                            1 (2%)                                                                       
      Endometrium, Fibrosis                                                      1 (2%)                                             
      Endometrium, Hyperplasia, Cystic                 1 (2%)       2 (4%)                                                          
   Vagina                                                          (1)                                                              
      Inflammation, Acute                                           1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (53)         (53)         (53)                                                
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Hypoplasia                                       1 (2%)                                                                       
      Myelofibrosis                                    2 (4%)       3 (6%)                                                          
      Pigmentation                                     1 (2%)                                                                       
      Myeloid Cell, Hyperplasia                                     4 (8%)                                                          
   Lymph Node                                         (53)         (52)         (53)                                                
      Mediastinal, Congestion                                                    2 (4%)                                             
      Renal, Congestion                                             1 (2%)                                                          
      Renal, Hemorrhage                                             1 (2%)                                                          
   Lymph Node, Mesenteric                             (52)         (52)         (53)                                                
      Congestion                                                                 1 (2%)                                             
      Edema                                            1 (2%)                                                                       
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)                                             
      Lymphocyte, Depletion Cellular                                             1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15 MG/KG     30 MG/KG                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Spleen                                             (53)         (53)         (53)                                                
      Angiectasis                                                   1 (2%)                                                          
      Fibrosis                                         1 (2%)                    1 (2%)                                             
      Hematopoietic Cell Proliferation Granulocytic    2 (4%)       5 (9%)                                                          
      Inflammation, Focal, Granulomatous                            1 (2%)                                                          
      Necrosis, Focal                                               1 (2%)                                                          
      Pigmentation                                     3 (6%)       1 (2%)       4 (8%)                                             
      Capsule, Fibrosis, Multifocal                                              1 (2%)                                             
   Thymus                                             (51)         (51)         (44)                                                
      Autolysis                                        1 (2%)                                                                       
      Cyst                                             2 (4%)                    1 (2%)                                             
      Hemorrhage                                       1 (2%)       1 (2%)       1 (2%)                                             
      Hyperplasia, Lymphoid                                                      1 (2%)                                             
      Medulla, Hyperplasia, Focal                                                1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (53)         (53)         (51)                                                
      Galactocele                                      5 (9%)                    5 (10%)                                            
      Hyperplasia                                     23 (43%)                  22 (43%)                                            
      Hyperplasia, Cystic                                           1 (2%)                                                          
      Inflammation, Acute                                           1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active, Multifocal                                   1 (2%)                                             
      Duct, Ectasia                                   23 (43%)     11 (21%)      2 (4%)                                             
   Skin                                               (53)         (52)         (52)                                                
      Face, Inflammation, Acute                                     1 (2%)                                                          
      Face, Inflammation, Chronic Active, Focal                                  1 (2%)                                             
      Subcutaneous Tissue, Hemorrhage                  1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (53)         (53)         (53)                                                
      Hyperostosis                                                               1 (2%)                                             
      Osteopetrosis                                    1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (53)         (53)         (53)                                                
      Congestion                                                                 2 (4%)                                             
      Hemorrhage, Focal                                             1 (2%)                                                          
      Hydrocephalus                                    1 (2%)                                                                       
      Inflammation, Acute, Focal                                    1 (2%)                                                          
      Inflammation, Chronic, Focal                                  1 (2%)                                                          
      Cerebellum, Cyst                                                           1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15 MG/KG     30 MG/KG                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
NERVOUS SYSTEM - CONT                                                                                                               
      Third Ventricle, Dilatation                      1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (53)         (53)         (53)                                                
      Congestion                                       1 (2%)       6 (11%)     13 (25%)                                            
      Fibrosis, Focal                                               1 (2%)                                                          
      Hemorrhage                                       1 (2%)       1 (2%)       1 (2%)                                             
      Inflammation, Chronic                            1 (2%)       1 (2%)       3 (6%)                                             
      Inflammation, Granulomatous, Multifocal                                    1 (2%)                                             
      Alveolar Epithelium, Hyperplasia, Focal                       1 (2%)       2 (4%)                                             
      Alveolus, Infiltration Cellular, Histiocyte      3 (6%)       3 (6%)       2 (4%)                                             
      Interstitium, Infiltration Cellular,                                                                                          
          Multifocal                                   1 (2%)                                                                       
      Perivascular, Inflammation, Chronic             14 (26%)                  12 (23%)                                            
   Nose                                               (52)         (53)         (48)                                                
      Autolysis                                                     4 (8%)                                                          
      Foreign Body                                                  1 (2%)       1 (2%)                                             
      Fungus                                           5 (10%)      1 (2%)       1 (2%)                                             
      Hemorrhage                                                    3 (6%)                                                          
      Inflammation, Chronic, Focal                     1 (2%)                                                                       
      Mucosa, Inflammation, Acute                                   6 (11%)      5 (10%)                                            
      Mucosa, Inflammation, Chronic Active             5 (10%)      2 (4%)       1 (2%)                                             
      Nasolacrimal Duct, Cyst                                       1 (2%)       1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Acute           4 (8%)       1 (2%)       6 (13%)                                            
      Nasolacrimal Duct, Inflammation, Chronic                                   4 (8%)                                             
      Nasolacrimal Duct, Inflammation, Chronic                                                                                      
          Active                                       1 (2%)       1 (2%)       3 (6%)                                             
      Sinus, Inflammation, Acute                                    1 (2%)       1 (2%)                                             
      Vein, Thrombosis                                              1 (2%)                                                          
   Trachea                                            (53)         (53)         (53)                                                
      Inflammation, Chronic                                                      2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)          (4)          (2)                                                 
      Bilateral, Lens, Cataract                                     1 (25%)                                                         
      Lens, Cataract                                   2 (67%)      2 (50%)      2 (100%)                                           
      Retina, Degeneration                             3 (100%)     1 (25%)      2 (100%)                                           
      Sclera, Mineralization, Focal                                              1 (50%)                                            
   Harderian Gland                                                              (1)                                                 
      Inflammation, Chronic                                                      1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15 MG/KG     30 MG/KG                                               
                                                   FEMALE        FEMALE       FEMALE                                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (53)         (53)         (52)                                                
      Autolysis                                                     7 (13%)      1 (2%)                                             
      Congestion                                                    3 (6%)       1 (2%)                                             
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Inflammation, Multifocal, Suppurative                                      1 (2%)                                             
      Mineralization, Focal                                         2 (4%)                                                          
      Mineralization, Multifocal                       9 (17%)      2 (4%)      15 (29%)                                            
      Nephropathy                                     46 (87%)     38 (72%)     35 (67%)                                            
      Cortex, Renal Tubule, Necrosis                                             1 (2%)                                             
      Cortex, Renal Tubule, Necrosis, Focal                         1 (2%)                                                          
      Renal Tubule, Epithelium, Pigmentation           3 (6%)       4 (8%)       2 (4%)                                             
   Urinary Bladder                                    (52)         (52)         (49)                                                
      Calculus Micro Observation Only, Multifocal      1 (2%)                                                                       
      Hemorrhage, Focal                                                          1 (2%)                                             
      Hyperplasia, Papillary                           1 (2%)                                                                       
      Infiltration Cellular, Lymphocyte                             1 (2%)                                                          
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15 MG/KG     30 MG/KG                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          70           70           70                                                  
  Scheduled Sacrifice                                 17           17           17                                                  
  Early Deaths                                                                                                                      
    Dead                                               8           11           20                                                  
    Moribund                                          17           21           15                                                  
    Accident                                           1                                                                            
    Dosing Accident                                                              2                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                27           21           16                                                  
  Animals Examined Microscopically                    53           53           53                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (53)         (53)         (53)                                                
      Wall, Inflammation, Chronic                                                1 (2%)                                             
   Intestine Large, Cecum                             (52)         (52)         (53)                                                
      Autolysis                                                     1 (2%)                                                          
      Inflammation, Acute                              2 (4%)       1 (2%)       1 (2%)                                             
      Parasite Metazoan                                1 (2%)                                                                       
   Intestine Large, Colon                             (53)         (53)         (53)                                                
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Infiltration Cellular, Lymphocyte                1 (2%)                                                                       
      Parasite Metazoan                               11 (21%)      6 (11%)     12 (23%)                                            
   Intestine Large, Rectum                            (53)         (52)         (52)                                                
      Inflammation, Acute                              1 (2%)                                                                       
      Parasite Metazoan                                5 (9%)                    2 (4%)                                             
   Intestine Small                                    (53)         (53)         (53)                                                
      Perivascular, Inflammation, Chronic                                        1 (2%)                                             
      Serosa, Inflammation, Chronic                                              1 (2%)                                             
   Intestine Small, Duodenum                          (52)         (53)         (53)                                                
      Autolysis                                        1 (2%)                                                                       
      Inflammation, Chronic                                                      1 (2%)                                             
      Necrosis, Acute, Focal                                                     1 (2%)                                             
   Intestine Small, Ileum                             (53)         (52)         (51)                                                
      Autolysis                                        1 (2%)       3 (6%)       1 (2%)                                             
      Parasite Metazoan                                                          1 (2%)                                             
   Intestine Small, Jejunum                           (51)         (52)         (52)                                                
      Autolysis                                        1 (2%)       2 (4%)                                                          
   Liver                                              (53)         (53)         (53)                                                
      Angiectasis                                      1 (2%)                                                                       
      Angiectasis, Focal                               1 (2%)       1 (2%)                                                          
      Basophilic Focus                                 9 (17%)      1 (2%)       5 (9%)                                             
      Basophilic Focus, Multiple                       3 (6%)      10 (19%)      3 (6%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15 MG/KG     30 MG/KG                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Clear Cell Focus                                              1 (2%)       1 (2%)                                             
      Congestion                                       1 (2%)       2 (4%)       1 (2%)                                             
      Cytoplasmic Alteration, Focal                    9 (17%)      3 (6%)       4 (8%)                                             
      Cytoplasmic Alteration, Multifocal               2 (4%)                                                                       
      Fatty Change, Diffuse                            1 (2%)                                                                       
      Fatty Change, Multifocal                         1 (2%)                                                                       
      Hepatodiaphragmatic Nodule                                    2 (4%)                                                          
      Hyperplasia, Focal                                            1 (2%)                                                          
      Inflammation, Acute, Multifocal                                            1 (2%)                                             
      Inflammation, Chronic                                         3 (6%)                                                          
      Inflammation, Granulomatous, Multifocal          1 (2%)       3 (6%)                                                          
      Necrosis, Acute, Focal                           2 (4%)       1 (2%)       3 (6%)                                             
      Pigmentation, Diffuse                            1 (2%)                                                                       
      Thrombosis                                       1 (2%)       1 (2%)                                                          
      Vacuolization Cytoplasmic, Focal                 1 (2%)       1 (2%)       2 (4%)                                             
      Artery, Thrombosis                               1 (2%)                                                                       
      Bile Duct, Hyperplasia                          20 (38%)     11 (21%)     17 (32%)                                            
      Centrilobular, Fatty Change                                   1 (2%)       1 (2%)                                             
      Centrilobular, Vacuolization Cytoplasmic                      1 (2%)                                                          
      Hepatocyte, Degeneration, Cystic, Focal          5 (9%)       3 (6%)       2 (4%)                                             
      Hepatocyte, Hypertrophy, Focal                                             1 (2%)                                             
   Mesentery                                          (2)          (1)          (2)                                                 
      Inflammation, Chronic                                                      1 (50%)                                            
      Fat, Necrosis, Chronic, Multifocal               1 (50%)                                                                      
      Fat, Necrosis, Focal                                          1 (100%)                                                        
   Pancreas                                           (52)         (53)         (52)                                                
      Atrophy, Focal                                  16 (31%)     20 (38%)     14 (27%)                                            
      Congestion, Focal                                             1 (2%)                                                          
      Cytoplasmic Alteration, Focal                    1 (2%)                                                                       
      Hyperplasia, Focal                                            1 (2%)                                                          
      Infiltration Cellular, Focal, Lymphocyte                                   1 (2%)                                             
      Inflammation, Chronic                                         1 (2%)                                                          
      Artery, Inflammation, Chronic                    1 (2%)                                                                       
      Artery, Mineralization                                        1 (2%)                                                          
      Duct, Ectasia, Focal                                          1 (2%)       1 (2%)                                             
      Perivascular, Inflammation, Chronic                                        2 (4%)                                             
   Salivary Glands                                    (52)         (53)         (53)                                                
      Atrophy, Diffuse                                 1 (2%)                                                                       
      Inflammation, Acute, Focal                                    3 (6%)                                                          
      Inflammation, Chronic                                         1 (2%)       2 (4%)                                             
      Duct, Ectasia, Focal                             1 (2%)                                                                       
      Duct, Inflammation, Acute                                     1 (2%)                                                          
      Duct, Inflammation, Chronic Active                                         1 (2%)                                             
      Periductular, Inflammation, Chronic                                        1 (2%)                                             
   Stomach                                            (53)         (52)         (53)                                                
      Perivascular, Inflammation, Chronic                                        1 (2%)                                             
      Serosa, Inflammation, Chronic                                              1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15 MG/KG     30 MG/KG                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Stomach, Forestomach                               (53)         (52)         (53)                                                
      Hyperplasia                                      1 (2%)                                                                       
      Inflammation, Acute                              3 (6%)       4 (8%)       3 (6%)                                             
      Inflammation, Chronic                            2 (4%)                    1 (2%)                                             
      Inflammation, Chronic Active                                  1 (2%)       1 (2%)                                             
      Mineralization                                                1 (2%)       2 (4%)                                             
      Necrosis, Focal                                  1 (2%)                                                                       
      Epithelium, Hyperplasia                          2 (4%)       6 (12%)      2 (4%)                                             
      Serosa, Inflammation, Chronic                                              1 (2%)                                             
   Stomach, Glandular                                 (52)         (52)         (53)                                                
      Hemorrhage, Focal                                                          1 (2%)                                             
      Infiltration Cellular, Focal, Lymphocyte                                   4 (8%)                                             
      Infiltration Cellular, Lymphocyte                             4 (8%)                                                          
      Inflammation, Acute                              1 (2%)       1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)       2 (4%)       1 (2%)                                             
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Mineralization                                   1 (2%)       4 (8%)       3 (6%)                                             
      Necrosis, Focal                                  2 (4%)       5 (10%)      2 (4%)                                             
   Tongue                                                                       (3)                                                 
      Epithelium, Hyperplasia, Focal                                             2 (67%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (53)         (53)         (52)                                                
      Inflammation, Acute                                           1 (2%)                                                          
      Aorta, Mineralization                                         1 (2%)       2 (4%)                                             
   Heart                                              (52)         (53)         (53)                                                
      Fibrosis, Focal                                  2 (4%)                                                                       
      Inflammation, Chronic                           48 (92%)     45 (85%)     46 (87%)                                            
      Mineralization                                   2 (4%)       3 (6%)       2 (4%)                                             
      Artery, Mineralization, Multifocal               1 (2%)                                                                       
      Atrium Left, Thrombosis                          5 (10%)      4 (8%)       3 (6%)                                             
      Perivascular, Inflammation, Chronic                                        1 (2%)                                             
      Valve, Thrombosis                                2 (4%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (52)         (51)         (53)                                                
      Cyst                                                          1 (2%)                                                          
      Hemorrhage, Focal                                                          1 (2%)                                             
      Hyperplasia                                                   1 (2%)                                                          
      Hyperplasia, Focal                               9 (17%)      8 (16%)     12 (23%)                                            
      Hypertrophy, Focal                               5 (10%)      5 (10%)      3 (6%)                                             
      Necrosis, Focal                                  1 (2%)       2 (4%)                                                          
      Vacuolization Cytoplasmic, Diffuse               2 (4%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15 MG/KG     30 MG/KG                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Vacuolization Cytoplasmic, Focal                 7 (13%)     10 (20%)      5 (9%)                                             
   Adrenal Gland, Medulla                             (51)         (50)         (53)                                                
      Hyperplasia, Focal                              10 (20%)      6 (12%)      7 (13%)                                            
      Mineralization, Focal                                                      1 (2%)                                             
      Thrombosis                                                    1 (2%)       1 (2%)                                             
      Bilateral, Hyperplasia, Focal                                 1 (2%)                                                          
   Islets, Pancreatic                                 (52)         (53)         (52)                                                
      Hyperplasia, Focal                               1 (2%)                                                                       
   Parathyroid Gland                                  (48)         (47)         (37)                                                
      Hyperplasia                                                   3 (6%)       4 (11%)                                            
      Hyperplasia, Focal                                            1 (2%)                                                          
   Pituitary Gland                                    (53)         (52)         (53)                                                
      Hemorrhage                                                    1 (2%)                                                          
      Pars Distalis, Angiectasis                       1 (2%)       3 (6%)       1 (2%)                                             
      Pars Distalis, Cyst                              2 (4%)       2 (4%)       1 (2%)                                             
      Pars Distalis, Hyperplasia                       8 (15%)      7 (13%)      6 (11%)                                            
      Pars Intermedia, Hyperplasia, Focal                           1 (2%)                                                          
      Pars Nervosa, Hyperplasia                        1 (2%)                                                                       
   Thyroid Gland                                      (53)         (53)         (53)                                                
      Ultimobranchial Cyst                             1 (2%)                                                                       
      C-Cell, Hyperplasia                             11 (21%)      6 (11%)      4 (8%)                                             
      Follicular Cell, Hyperplasia                     3 (6%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (52)         (50)         (52)                                                
      Duct, Epithelium, Degeneration                   1 (2%)                                                                       
   Penis                                                                        (1)                                                 
      Inflammation, Acute                                                        1 (100%)                                           
   Preputial Gland                                    (51)         (52)         (52)                                                
      Cyst                                                          1 (2%)                                                          
      Ectasia                                                                    1 (2%)                                             
      Hyperplasia                                                   2 (4%)                                                          
      Inflammation, Acute                             10 (20%)      7 (13%)      8 (15%)                                            
      Inflammation, Chronic                           18 (35%)     28 (54%)     16 (31%)                                            
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Duct, Hyperplasia, Squamous                      1 (2%)                                                                       
   Prostate                                           (48)         (52)         (53)                                                
      Hyperplasia, Focal                               4 (8%)       4 (8%)       1 (2%)                                             
      Inflammation, Acute                              6 (13%)                   4 (8%)                                             
      Inflammation, Chronic                            1 (2%)       5 (10%)      2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15 MG/KG     30 MG/KG                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Inflammation, Chronic Active                                  2 (4%)                                                          
      Mineralization                                                             2 (4%)                                             
      Epithelium, Degeneration, Focal                  1 (2%)                                                                       
   Testes                                             (53)         (51)         (52)                                                
      Atrophy                                          6 (11%)      6 (12%)      1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Infarct, Diffuse                                                           1 (2%)                                             
      Mineralization, Focal                            1 (2%)                                                                       
      Bilateral, Interstitial Cell, Hyperplasia        1 (2%)       1 (2%)                                                          
      Interstitial Cell, Hyperplasia                   6 (11%)      6 (12%)      6 (12%)                                            
      Seminiferous Tubule, Degeneration                1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (53)         (52)         (52)                                                
      Hyperplasia                                      2 (4%)       2 (4%)                                                          
      Hyperplasia, Megakaryocyte                       1 (2%)                                                                       
      Hypoplasia                                       2 (4%)                    2 (4%)                                             
      Myelofibrosis                                                 2 (4%)       2 (4%)                                             
      Myeloid Cell, Hyperplasia                        2 (4%)       3 (6%)       1 (2%)                                             
   Lymph Node                                         (53)         (52)         (53)                                                
      Axillary, Congestion                             1 (2%)                                                                       
      Axillary, Hyperplasia                                         1 (2%)                                                          
      Iliac, Hyperplasia, Plasma Cell                  1 (2%)                                                                       
      Iliac, Inflammation, Focal, Granulomatous        1 (2%)                                                                       
      Inguinal, Infiltration Cellular, Plasma Cell                  1 (2%)                                                          
      Inguinal, Inflammation, Acute, Multifocal        1 (2%)                                                                       
      Mediastinal, Congestion                          5 (9%)                    2 (4%)                                             
      Mediastinal, Hemorrhage                                       1 (2%)                                                          
      Mediastinal, Hyperplasia                         1 (2%)       1 (2%)                                                          
      Pancreatic, Congestion                           1 (2%)                                                                       
      Pancreatic, Fibrosis, Focal                                                1 (2%)                                             
      Pancreatic, Inflammation, Chronic                             1 (2%)                                                          
      Renal, Hemorrhage                                             1 (2%)                                                          
   Lymph Node, Mesenteric                             (53)         (52)         (53)                                                
      Congestion                                       1 (2%)       1 (2%)       1 (2%)                                             
      Hemorrhage                                                    2 (4%)                                                          
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Hyperplasia, Re Cell                                                       1 (2%)                                             
      Necrosis, Focal                                               1 (2%)                                                          
   Spleen                                             (53)         (53)         (53)                                                
      Congestion                                                                 2 (4%)                                             
      Fibrosis                                         1 (2%)       5 (9%)       1 (2%)                                             
      Fibrosis, Focal                                  1 (2%)                                                                       
      Hematopoietic Cell Proliferation                              2 (4%)                                                          
      Hematopoietic Cell Proliferation Granulocytic    2 (4%)       1 (2%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15 MG/KG     30 MG/KG                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hemorrhage, Multifocal                           1 (2%)                                                                       
      Necrosis, Focal                                               1 (2%)                                                          
      Pigmentation, Diffuse                            1 (2%)                                                                       
      Capsule, Fibrosis, Focal                         2 (4%)                                                                       
   Thymus                                             (47)         (48)         (50)                                                
      Congestion                                                                 2 (4%)                                             
      Cyst, Multiple                                   1 (2%)                    3 (6%)                                             
      Ectasia                                                       1 (2%)                                                          
      Hemorrhage                                       2 (4%)                                                                       
      Hyperplasia                                                   1 (2%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (53)         (52)         (53)                                                
      Fibrosis                                                      1 (2%)                                                          
      Hyperplasia                                      2 (4%)       6 (12%)      9 (17%)                                            
      Hyperplasia, Cystic                              1 (2%)                    2 (4%)                                             
      Mineralization                                                1 (2%)                                                          
      Pigmentation                                                  1 (2%)       1 (2%)                                             
      Duct, Ectasia                                    2 (4%)       8 (15%)                                                         
   Skin                                               (53)         (51)         (53)                                                
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Acute                              1 (2%)       1 (2%)                                                          
      Inflammation, Chronic, Focal                                               1 (2%)                                             
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Face, Inflammation, Acute, Focal                                           1 (2%)                                             
      Subcutaneous Tissue, Edema                                    1 (2%)                                                          
      Subcutaneous Tissue, Inflammation, Acute         1 (2%)                                                                       
      Subcutaneous Tissue, Necrosis                    1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (53)         (52)         (52)                                                
      Fibrous Osteodystrophy                           1 (2%)       4 (8%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (53)         (53)         (53)                                                
      Congestion                                       1 (2%)                                                                       
      Hemorrhage, Focal                                1 (2%)       1 (2%)       1 (2%)                                             
      Hydrocephalus                                                              1 (2%)                                             
      Cerebellum, Pigmentation, Focal                                            1 (2%)                                             
      Meninges, Vein, Cerebrum, Thrombosis                          1 (2%)                                                          
      Thalamus, Inflammation, Chronic, Focal                                     1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15 MG/KG     30 MG/KG                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (53)         (53)         (53)                                                
      Congestion                                       2 (4%)       6 (11%)     10 (19%)                                            
      Fibrosis, Multifocal                                          2 (4%)                                                          
      Hemorrhage, Focal                                             2 (4%)                                                          
      Inflammation, Acute, Focal                       2 (4%)                                                                       
      Inflammation, Chronic                            3 (6%)       4 (8%)       4 (8%)                                             
      Inflammation, Focal, Granulomatous               4 (8%)                                                                       
      Mineralization, Focal                            1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                              1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia, Focal                       1 (2%)                                                          
      Alveolus, Infiltration Cellular, Histiocyte      2 (4%)       4 (8%)       1 (2%)                                             
      Alveolus, Pigmentation                                        1 (2%)                                                          
      Artery, Media, Hypertrophy                                    1 (2%)                                                          
      Bronchiole, Inflammation, Chronic Active,                                                                                     
           Multifocal                                                            1 (2%)                                             
      Peribronchial, Infiltration Cellular,                                                                                         
          Lymphocyte                                                             1 (2%)                                             
      Perivascular, Inflammation, Chronic              4 (8%)       2 (4%)       2 (4%)                                             
      Pleura, Fibrosis, Focal                                                    1 (2%)                                             
      Pleura, Infiltration Cellular, Focal,                                                                                         
          Histiocyte                                                             1 (2%)                                             
      Subpleura, Inflammation, Chronic                                           2 (4%)                                             
   Nose                                               (52)         (53)         (53)                                                
      Autolysis                                                     2 (4%)       3 (6%)                                             
      Congestion                                                                 2 (4%)                                             
      Cyst                                             3 (6%)                                                                       
      Foreign Body                                                  3 (6%)                                                          
      Fungus                                           8 (15%)      8 (15%)      5 (9%)                                             
      Metaplasia, Squamous                                                       6 (11%)                                            
      Mucosa, Concretion, Focal                        1 (2%)                                                                       
      Mucosa, Inflammation, Acute                      7 (13%)      4 (8%)       9 (17%)                                            
      Mucosa, Inflammation, Chronic                                 3 (6%)                                                          
      Mucosa, Inflammation, Chronic Active             9 (17%)      8 (15%)     15 (28%)                                            
      Nasolacrimal Duct, Inflammation, Acute           3 (6%)       1 (2%)       1 (2%)                                             
      Nasolacrimal Duct, Inflammation, Chronic         1 (2%)                    2 (4%)                                             
      Respiratory Epithelium, Hyperplasia              2 (4%)                                                                       
      Respiratory Epithelium, Hyperplasia,                                                                                          
          Papillary                                                 1 (2%)                                                          
      Vomeronasal Organ, Inflammation, Acute                                     1 (2%)                                             
   Trachea                                            (53)         (53)         (53)                                                
      Inflammation, Chronic                            2 (4%)                    2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   15                                                              
NTP Experiment-Test: 05705-02         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                       MONOCHLOROACETIC ACID                                   Date: 09/18/94  
Route: GAVAGE                                                                                                     Time: 21:14:39  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15 MG/KG     30 MG/KG                                               
                                                   MALE          MALE         MALE                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (4)          (3)          (3)                                                 
      Bilateral, Lens, Cataract                                     1 (33%)      1 (33%)                                            
      Lens, Cataract                                   2 (50%)      1 (33%)      2 (67%)                                            
      Retina, Degeneration                             1 (25%)                   2 (67%)                                            
      Sclera, Mineralization, Focal                    3 (75%)      3 (100%)     1 (33%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (53)         (53)         (53)                                                
      Autolysis                                                     6 (11%)                                                         
      Calculus Micro Observation Only                  1 (2%)                                                                       
      Congestion                                                    1 (2%)       1 (2%)                                             
      Mineralization, Multifocal                       1 (2%)                                                                       
      Nephropathy                                     53 (100%)    51 (96%)     48 (91%)                                            
      Cortex, Cyst                                     1 (2%)       2 (4%)                                                          
      Medulla, Inflammation, Multifocal                1 (2%)                                                                       
      Pelvis, Calculus Gross Observation               1 (2%)                                                                       
      Pelvis, Inflammation, Acute                      2 (4%)       1 (2%)                                                          
      Pelvis, Transitional Epithelium, Hyperplasia     2 (4%)       3 (6%)       2 (4%)                                             
      Renal Tubule, Epithelium, Pigmentation           3 (6%)       1 (2%)       1 (2%)                                             
   Urinary Bladder                                    (51)         (52)         (53)                                                
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation, Acute                              2 (4%)                    1 (2%)                                             
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
      Transitional Epithelium, Hyperplasia, Focal,                                                                                  
           Papillary                                                             1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   16                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------